Skip NavigationSkip to Content
Return Return to Search Results

Genetic basis of cancer of the kidney: Disease specific approaches to therapy

  1. Author:
    Linehan, W. M.
    Vasselli, J.
    Srinivasan, R.
    Walther, M. M.
    Merino, M.
    Choyke, P.
    Vocke, C.
    Schmidt, L.
    Isaacs, J. S.
    Glenn, G.
    Toro, J.
    Zbar, B.
    Bottaro, D.
    Neckers, L.

  2. Author Address

    NCI, Urol Oncol Branch, Bethesda, MD 20892 USA. NCI, Immunobiol Lab, Bethesda, MD 20892 USA. NCI, Pathol Lab, Bethesda, MD 20892 USA. NCI, Mol Imaging Program, Bethesda, MD 20892 USA. NCI, Ctr Canc Res, Bethesda, MD 20892 USA. NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA. NCI, Sci Applicat Int Corp Frederick Inc, Basic Res Program, Frederick, MD 21701 USA Linehan, WM, NCI, Urol Oncol Branch, Bldg 10,Room 2B47, Bethesda, MD 20892 USA
    1. Year: 2004
    2. Date: SEP 15
  2. Journal: Clinical Cancer Research
    1. 10
    2. 18, Part 2 Suppl. S
    3. Pages: 6282S-6289S
  4. Type of Article: Article
  1. Abstract:

    Studies during the past two decades have shown that kidney cancer is not a single disease; it is made up of a number of different types of cancer that occur in this organ. Clear cell renal carcinoma is characterized by mutation of the VHL gene. The VHL gene product forms a heterotrimeric complex with elongin C, elongin B, and Cul-2 to target hypoxia-inducible factors 1 and 2alpha for ubiquitin-mediated degradation. VHL-/- clear cell renal carcinoma overexpresses epidermal growth factor receptor and transforming growth factor alpha. Both hypoxia-inducible factor 1alpha. and the epidermal growth factor receptor are potential therapeutic targets in clear cell renal carcinoma. Studies of the hereditary form of renal cell carcinoma (RCC) associated with hereditary papillary renal carcinoma (HPRC) determined that the c-Met proto-oncogene on chromosome 7 is the gene for HPRC and for a number of sporadic papillary RCCs. The HPRC c-Met mutations are activating mutations in the tyrosine kinase domain of the gene. The gene for a new form of hereditary RCC (Birt Hogg Dube syndrome) associated with cutaneous tumors, lung cysts, and colon polyps or cancer has recently been identified. Studies are currently under way to determine what type of gene BHD is and how damage to this gene leads to kidney cancer. Individuals affected with hereditary leiomyomatosis renal cell carcinoma are at risk for the development of cutaneous leiomyomas, uterine leiomyomas (fibroids), and type 2 papillary RCC. The HLRC gene has been found to be the Krebs cycle enzyme, fumarate hydratase. Studies are under way to understand the downstream pathway of this cancer gene

    See More

  1. Keywords:

External Sources

  1. View record in Web of Science®
  2. WOS: 000224080600002

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel